Eric Shaff

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.

Jefferies Broadview, a division of Jefferies & Company, Inc. provides services to the information technology, communications, healthcare technology and digital media industries. The firm addresses six major technology segments: communications technology, semiconductors and electronics manufacturing, enterprise software, digital media, and information technology services. Jefferies Broadview consists of 90 investment bankers operating in the US, Europe and Asia. The company provides investment banking services including debt and equity underwriting, private placements, M&A and restructuring advisory services. The company is headquartered in New York, NY.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.